Patentees suing alleged infringers have learned from a long history of federal district court and Federal Circuit rulings that (paraphrasing the Miranda warning given to criminal suspects) “anything you say…
In an en banc decision on July 12, 2016 in The Medicines Co. v. Hospira, Inc., the Federal Circuit established the circumstances under which a product manufactured according to product-by-process…
Summary Voters in the U.K. recently passed a referendum paving the way for the U.K. to leave the European Union (EU). In response, British Prime Minister David Cameron resigned on…
The new Post-Prosecution Pilot (“P3”) program provides a pathway for patent applicants to make an in-person presentation to a panel of patent examiners as an alternative to existing options for…
The medical device industry has been struck by a wave of uncertainty in the wake of the United Kingdom’s (UK) historic vote to leave the European Union (EU). Until the…
Biosimilar Applicants Must Provide Notice of Commercial Launch What You Need To Know Case Background In an opinion released today in Amgen v. Apotex, the Federal Circuit held biosimilar applicants…
The Defend Trade Secrets Act signed into law in May filled a gap in existing law and allows companies to protect their trade secrets across state lines and outside of…
Knobbe Martens Olson & Bear LLP has once again been recognized by The Legal 500, an annually published directory of the top legal service providers worldwide, for its outstanding legal work in…
The PTAB Does Not Have to Consider New Arguments Raised in IPR Reply Briefs In Intelligent Bio-Systems, Inc. v. Illumina Cambridge Ltd., Appeal No. 2015-1693, the Federal Circuit upheld a…
Coca-Cola has Acquired Secondary Meaning in ZERO for Colas In an opposition proceeding before the TTAB, Royal Crown (RC) and Dr. Pepper/Seven Up sought to prevent registration of seventeen applications…
